Posted by Michael Wonder on 25 Feb 2021
Teleflex announces submission of biologics license application for its investigational freeze dried plasma
24 February 2021 - Submission is eligible for priority review and accelerated approval.
Teleflex has announced it has submitted a biologics license application to the U.S. FDA for its investigational freeze dried plasma candidate.
